Teva Pharmaceutical Industries Ltd ADR diskutieren
Teva Pharmaceutical Industries Ltd ADR
WKN: 883035 / Symbol: TEVA / Name: Teva Pharma / Aktie / Pharmazeutika / Large Cap /
15,80 €
-1,25 %
Buy Teva Pharmaceutical Industries Ltd ADR
Buy Teva Pharmaceutical Industries Ltd ADR
We offer Legitimately Cash & Asset Backed Financial Instruments on Lease
Worldwide project financing, Loans, BG, SBLC, DLC, LC
We arrange Following Bank Instruments
Letter of Credit ( LC)
From Various Banks in Singapore / HongKong / Europe /USA
Used For Import / Export Business and Trade Finance .
90/180DAYS
Bank Guarantee ( BG )
Fresh Cut
Slightly Seasoned
Seasoned
Stand By Letter of Credit ( SBLC )
90DAYS / 180/ 365DAYS
Regards
[email protected]
Steffen
Worldwide project financing, Loans, BG, SBLC, DLC, LC
We arrange Following Bank Instruments
Letter of Credit ( LC)
From Various Banks in Singapore / HongKong / Europe /USA
Used For Import / Export Business and Trade Finance .
90/180DAYS
Bank Guarantee ( BG )
Fresh Cut
Slightly Seasoned
Seasoned
Stand By Letter of Credit ( SBLC )
90DAYS / 180/ 365DAYS
Regards
[email protected]
Steffen
Buy with target price 10.0
Buy beendet
Buy beendet
Buy Teva Pharmaceutical Industries Ltd ADR
Sell with target price 10.0
Sell Teva Pharmaceutical Industries Ltd ADR
Teva Pharmaceutical Industries Limited (NYSE: TEVA) was upgraded by analysts at Evercore ISI to an "outperform" rating.
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target raised by analysts at Bank of America Co. from $12.00 to $13.00. They now have a "buy" rating on the stock.
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries Limited (NYSE: TEVA) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $13.00 price target on the stock, up previously from $11.00.
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries Limited (NYSE: TEVA) is now covered by analysts at HSBC Holdings plc. They set a "buy" rating and a $13.00 price target on the stock.
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries Limited (NYSE: TEVA) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $14.00 price target on the stock, up previously from $10.00.
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target raised by analysts at Barclays PLC from $14.00 to $15.00. They now have an "overweight" rating on the stock.
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target raised by analysts at Barclays PLC from $15.00 to $17.00. They now have an "overweight" rating on the stock.
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries Limited (NYSE: TEVA) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $19.00 price target on the stock, up previously from $12.00.
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target raised by analysts at Barclays PLC from $17.00 to $20.00. They now have an "overweight" rating on the stock.
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $20.00 price target on the stock, up previously from $19.00.
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target raised by analysts at Bank of America Co. from $18.00 to $21.00. They now have a "buy" rating on the stock.
Ratings data for TEVA provided by MarketBeat
Neueste Beiträge
Tigress_Financial in Discuss Carnival Paired Ctf